BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

7:50 AM
 | 
Feb 08, 2017
 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Bladder cancer

In vitro studies suggest inhibiting DNM2 could help treat metastatic bladder cancer. In a human bladder cancer cell line, a DNM2 inhibitor tool compound...

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >